The Patent Finder

Curadis GmbH

Also on record
Records under this name other than the patents Curadis GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 6 of 6 · Back to Curadis GmbH

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,610,292Uses for 4,17β-dihydroxyandrost-4-ene-3-one
Lapsed on the fee record
Ended Apr 4, 2025 · USPTO record
Lapsed on the fee recordEnded Apr 4, 2025USPTO record
US 9,138,477Uses for 4,17β-dihydroxyandrost-4-ene-3-one
Lapsed on the fee record
Ended Sep 22, 2023 · USPTO record
Lapsed on the fee recordEnded Sep 22, 2023USPTO record
US 9,114,163Medication against breast cancer and related diseases
Lapsed on the fee record
Ended Aug 25, 2023 · USPTO record
Lapsed on the fee recordEnded Aug 25, 2023USPTO record
US 10,265,328C-19 steroids for specific therapeutic uses
Lapsed on the fee record
Ended Apr 23, 2023 · USPTO record
Lapsed on the fee recordEnded Apr 23, 2023USPTO record
US 8,278,291Treatment of wrinkles and strias with 4-hydroxyandrostenedione or a derivative thereof
Term ended
Term ended Jul 28, 2020 · USPTO record
Term endedTerm ended Jul 28, 2020USPTO record
US 8,343,948Medicament for preventing and/or treating mammary carcinoma, containing a steroidal aromatase inhibitor
Term ended
Term ended May 5, 2020 · USPTO record
Term endedTerm ended May 5, 2020USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited